Overview
All Cogent™ TYPE-C™ columns share the same underlying silica hydride particle technology. What differentiates one column from another is the ligand chemistry attached to the silica hydride surface.
Examples include:
- Diamond Hydride™
- Phenyl Hydride™
- Amide™
- Bidentate C18™
- Bidentate C8™
- Cholesterol™
- Diol™
- Silica-C™
- Undecanoic Acid™
Although the silica hydride support remains the same, each ligand modifies the surface interactions available to analytes and therefore changes chromatographic selectivity.
Understanding the Role of the Ligand
The ligand bonded to the silica hydride surface influences how analytes interact with the stationary phase.
Depending on the chemistry, the ligand may contribute:
- Hydrophobic interactions
- Aromatic interactions
- Hydrogen bonding
- Dipole interactions
- Shape selectivity
- Polar retention characteristics
As a result, two TYPE-C™ columns may behave quite differently even when operated under identical chromatographic conditions.
Influence on HILIC and Reversed Phase Behavior
One of the unique characteristics of TYPE-C™ silica hydride technology is its ability to operate under multiple chromatographic modes, including:
- HILIC
- Reversed Phase (RP)
- Normal Phase (NP)
The extent to which HILIC or reversed phase behavior dominates is strongly influenced by the ligand attached to the silica hydride surface.
Less Modified Surfaces
Columns with little or no hydrophobic ligand coverage tend to exhibit stronger HILIC retention characteristics.
Examples include:
- Diamond Hydride™
- Silica-C™
These phases are often selected when strong retention of polar compounds is desired.
More Hydrophobic Ligands
As ligand size, surface coverage, and carbon loading increase, reversed phase behavior generally becomes more dominant.
Examples include:
- Bidentate C18™
- Bidentate C8™
- Cholesterol™
These columns provide stronger hydrophobic interactions and are often selected for non-polar to moderately polar analytes.
Selectivity Tuning During Method Development
Changing the ligand chemistry can significantly alter separation performance even while maintaining the same silica hydride support platform.
Examples include:
Polar Compound Methods
When analyzing:
- Metabolites
- Organic acids
- Amines
- Peptides
- Polar pharmaceuticals
A more HILIC-oriented phase such as Diamond Hydride™, Amide™, or Silica-C™ may provide the desired retention.
Hydrophobic Compound Methods
When analyzing:
- Neutral pharmaceuticals
- Hydrophobic impurities
- Lipophilic compounds
A more hydrophobic ligand such as Bidentate C18™ or Cholesterol™ may provide better selectivity.
Advantages of the TYPE-C™ Platform
Because these columns share the same silica hydride support technology, users can investigate multiple selectivity options while remaining within the same column family.
Potential benefits include:
- Simplified method development
- Consistent column quality
- Broad selectivity choices
- HILIC and reversed phase flexibility
- Easier comparison of retention mechanisms
This can be particularly useful when developing new methods for challenging analytes.
General Selection Guidelines
Diamond Hydride™
Often selected for:
- HILIC methods
- LC-MS applications
- Highly polar compounds
Amide™
Often selected for:
- Polar compounds
- Carbohydrates
- HILIC separations
Phenyl Hydride™
Often selected when:
- Aromatic selectivity is important
- π-π interactions may enhance separations
Bidentate C18™ and Bidentate C8™
Often selected for:
- Reversed phase separations
- Hydrophobic analytes
- Traditional RP method development
Cholesterol™
Often selected when:
- Shape selectivity is important
- Steric interactions influence retention
Key Takeaways
- The primary difference between TYPE-C™ columns is the ligand attached to the silica hydride surface.
- Ligand chemistry controls chromatographic selectivity.
- Less hydrophobic ligands generally support stronger HILIC retention.
- Larger, more hydrophobic ligands generally promote stronger reversed phase behavior.
- TYPE-C™ columns provide flexibility for HILIC, reversed phase, and normal phase applications.
- Method developers can optimize selectivity by choosing the ligand chemistry best suited to the analytes of interest.
